Search results
Clinical Trials: Focus on Quality Over Quantity of Life
Medscape· 5 days agoDr Maurie Markman discusses the need for pragmatic studies focusing on patient quality of life.
Competition from 'skinny label' generics saved medicare billions, according to report
Medical Xpress· 3 days agoAn analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that...
Superbug Slayer: New Class of Antibiotics Proves Potent Against Multi-Drug Resistant Bacteria
SciTechDaily· 6 days agoA new class of antibiotics capable of combating multi-drug resistant bacteria and treating bloodstream infections in mice has been unveiled by Uppsala University scientists. Scientists at Uppsala ...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 4 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
Women need not fear menopause hormone drugs, major health study finds
Anchorage Daily News· 6 days agoMore than two decades ago, the shocking results of a major women’s health study challenged the...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press· 6 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 6 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
KEYT 3 Santa Barbara· 6 days agoUS challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 6 days agoThe letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and...
Quest Diagnostics carves out PathAI’s digital pathology lab, plots AI ramp up
FierceBiotech· 6 days agoQuest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings...